HD Clinical Studies, Hope

uniQure Announces First Two Patients Treated in Phase I/II Clinical Trial of AMT130 for the Treatment of Huntington’s Disease

In case you missed uniQure announcement regarding AMT-130, I’m posting the great news for the Huntington’s Disease community around the world.  One of the locations for a clinical for AMT-130 is Ohio State.

Ohio-State-conducts-1st-gene-therapy-clinical-trial-for-Huntington-

~ Milestone Marks the First-in-Human AAV Gene Therapy Trial for Huntington’s Disease ~ Lexington, MA and Amsterdam, the Netherlands, June 19, 2020 —

uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the first two patients in the Phase I/II clinical trial of AMT-130 for the treatment of Huntington’s disease have been treated. To read the complete news release, visitAMT-130_Huntingtons_Disease_FINAL.pdf

I’m a Huntington’s disease advocate, the Chair for HDSA San Francisco Bay Area Affiliate, a blogger and the author of the nonfiction book, Watching Their Dance: Three Sisters, a Genetic Disease and Marrying into a Family At Risk for Huntington’s.

John and I have donated 100% of the profit from the book to the nonprofit, Huntington’s Disease Society of America (HDSA).  To date, we’ve gifted over $15,000.00. Review by GoodreadsGoodreads.com-Watching-Their-Dance

My family wants to see the eradication of this horrific disease that has devastated the Marin Family for generations.

We Can Never Lose HOPE……………

                     

 

Previous Post Next Post

You Might Also Like

No Comments

Leave a Reply

%d bloggers like this: